SOPHiA GENETICS S.A. (SOPH) Total Return Calculator with Dividends Reinvested

SOPHiA GENETICS S.A.

Popular:

The total return for SOPHiA GENETICS S.A. (SOPH) stock is +75.24% over the past 12 months. So far it's up 18.20% this year. The 5-year total return is -67.06%, meaning $10,000 invested in SOPH stock 5 years ago would be worth $3,294 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in SOPH 1 year ago, it would be worth $18,548 today — you'd have gained $8,548.

With Dividends Reinvested$18,548+85.48%

Price Only (No DRIP)$18,548+85.48%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in SOPH

1Y$17,524+$7,524 (+75.2%)75.2% CAGR

3Y$14,227+$4,227 (+42.3%)12.5% CAGR

5Y$3,294-$6,706 (-67.1%)-19.9% CAGR

10Y$3,294-$6,706 (-67.1%)-10.5% CAGR

15Y$3,294-$6,706 (-67.1%)-7.1% CAGR

20Y$3,294-$6,706 (-67.1%)-5.4% CAGR

30Y$3,294-$6,706 (-67.1%)-3.6% CAGR

SOPHiA GENETICS S.A. did not pay dividends during this period. Total return = price return.

Loading SOPH total return...

As of 2026-06-28

Performance Summary

Best Year+109.33%2023

Worst Year-85.89%2022

Max Drawdown-25.72%2026-01-22 → 2026-03-03 · Recovered 2026-06-24

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+18.20%	—	+23.13%	—	$11,820
1Y	+75.24%	75.24%	+85.48%	—	$17,524
3Y	+42.27%	12.47%	+48.20%	—	$14,227
5Y	-67.06%	-19.92%	-65.69%	—	$3,294
10Y	-67.06%	-10.51%	-65.69%	—	$3,294
15Y	-67.06%	-7.14%	-65.69%	—	$3,294
20Y	-67.06%	-5.40%	-65.69%	—	$3,294
30Y	-67.06%	-3.63%	-65.69%	—	$3,294

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-3.64%	-3.64%	—	+0.41%	-4.1pp
2025	+46.39%	+46.39%	—	+16.64%	+29.8pp
2024	-36.44%	-36.44%	—	+24.00%	-60.4pp
2023	+109.33%	+109.33%	—	+24.81%	+84.5pp
2022	-85.89%	-85.89%	—	-19.95%	-65.9pp

SOPH outperformed the S&P 500 by 54.40pp over the past year (+75.24% vs +20.84%).

Loading summary...

SOPH Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
SOPHSOPHiA GENETICS S.A.	$412M	+14.8%	+18.2%	+75.2%	—	+42.3%	-67.1%	-67.1%
NTRANatera, Inc.	$37.5B	+30.3%	+13.6%	+51.3%	—	+421.5%	+117.1%	+1830.0%
EXASExact Sciences Corporation	$20.0B	—	+3.1%	+105.0%	—	+11.9%	-18.4%	+809.1%
VCYTVeracyte, Inc.	$4.8B	+36.8%	+33.9%	+111.2%	—	+121.5%	+39.8%	+1024.0%
CDNACareDx, Inc	$1.5B	+33.8%	+41.7%	+43.7%	—	+223.0%	-71.4%	+471.2%
ILMNIllumina, Inc.	$26.8B	+21.6%	+30.3%	+91.3%	—	-6.1%	-61.5%	+29.7%
PACBPacific Biosciences of California, Inc.	$512M	+31.0%	-21.7%	+20.0%	—	-88.6%	-95.6%	-82.3%
FLGTFulgent Genetics, Inc.	$567M	+13.0%	-25.2%	-2.0%	—	-48.5%	-77.1%	+108.4%
TMOThermo Fisher Scientific Inc.	$190.7B	+14.5%	-16.8%	+22.2%	+0.4pp	-4.8%	+0.8%	+246.3%
DHRDanaher Corporation	$138.5B	+13.2%	-17.9%	-3.7%	+0.7pp	-8.8%	-18.1%	+235.5%
RGENRepligen Corporation	$8.3B	+27.6%	-15.8%	+12.2%	—	-8.1%	-28.2%	+484.7%

Compare:SOPH vs NTRA SOPH vs EXAS SOPH vs VCYT SOPH vs NTRA vs EXAS

About SOPH Dividend Returns

SOPHiA GENETICS S.A. (SOPH) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of SOPH over the past year?

SOPHiA GENETICS S.A. (SOPH) delivered a return of 75.24% over the past year. Since SOPH does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in SOPH be worth today?

A $10,000 investment in SOPHiA GENETICS S.A. one year ago would be worth $17,524 today, representing a gain of $7,524.

Q3Does SOPH pay dividends?

SOPHiA GENETICS S.A. (SOPH) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SOPH, the total return equals the price-only return.

Q4Did SOPH beat the S&P 500?

Yes, SOPHiA GENETICS S.A. (SOPH) outperformed the S&P 500 by 54.40 percentage points over the past year. SOPH delivered a total return of 75.24%, compared to the S&P 500's 20.84%. This 54.40pp alpha means investors in SOPH earned more than a passive S&P 500 index fund.

Q5What is SOPH's worst drawdown?

SOPHiA GENETICS S.A. (SOPH) experienced a maximum drawdown of -25.72% over the past year, declining from its peak on 2026-01-22 to its trough on 2026-03-03. The stock recovered to its prior peak by 2026-06-24. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is SOPH's long-term total return over 10, 20, or 30 years?

Here are SOPHiA GENETICS S.A. (SOPH)'s long-term returns with dividends reinvested. Over 10 years, the total return is -67.1% (-10.5% CAGR) — $10,000 would have grown to $3,294. Over 20 years: -67.1% total return (-5.4% CAGR) — $10,000 → $3,294. Over 30 years: -67.1% total return (-3.6% CAGR) — $10,000 → $3,294. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was SOPH's best and worst year?

SOPHiA GENETICS S.A.'s best calendar year was 2023 with a total return of 109.3%. Its worst year was 2022 with a total return of -85.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 195.2 percentage points.

How much would $100/month in SOPH be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →